Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene delivery, protein sciences and clinical translation — to leap beyond the limitations of current gene therapies.
Powered by our novel non-viral DNA delivery system, we are on a path to achieve higher standards for potency, durability, redosability and safety. Together, we are working to reshape the treatment landscape for people in dire need of better options.
Company Details
- Employees
- 31
- Founded
- -
- Address
- 231 W Chestnut Ave, Monrovia,california 91016,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://RampartBio.com
- HQ
- Monrovia, California
Rampart Bioscience Questions
Rampart Bioscience's website is http://RampartBio.com
Rampart Bioscience's LinkedIn profile is https://www.linkedin.com/company/rampart-bioscience
Rampart Bioscience has
31 employees.
View email and phone details for 31
employees at Rampart Bioscience.
Rampart Bioscience's industry is
Biotechnology Research
Rampart Bioscience's top competitors are
Latigo Biotherapeutics, Inc.,
Poseida Therapeutics, Inc.,
Recode Therapeutics,
Seaport Therapeutics,
Generation Bio,
Full Circles Therapeutics Inc.,
Orsobio,
Triveni Bio,
Aiolos Bio,
Capricor Therapeutics, Inc..
Rampart Bioscience's categories are Biotechnology Research
Rampart Bioscience's founding year is 2019
